Cutter & Co Brokerage’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,838
Closed -$6.87M 135
2025
Q1
$6.87M Buy
10,838
+2,880
+36% +$1.83M 1.63% 15
2024
Q4
$5.67M Buy
7,958
+293
+4% +$209K 1.38% 16
2024
Q3
$8.06M Sell
7,665
-111
-1% -$117K 1.82% 8
2024
Q2
$8.17M Sell
7,776
-50
-0.6% -$52.6K 1.98% 8
2024
Q1
$7.53M Sell
7,826
-57
-0.7% -$54.9K 1.85% 8
2023
Q4
$6.92M Sell
7,883
-184
-2% -$162K 1.92% 9
2023
Q3
$6.64M Sell
8,067
-54
-0.7% -$44.4K 1.94% 9
2023
Q2
$5.84M Sell
8,121
-20
-0.2% -$14.4K 1.72% 10
2023
Q1
$6.69M Sell
8,141
-57
-0.7% -$46.8K 2.09% 8
2022
Q4
$5.91M Sell
8,198
-425
-5% -$307K 2% 7
2022
Q3
$5.94M Sell
8,623
-243
-3% -$167K 2.21% 6
2022
Q2
$5.24M Sell
8,866
-20
-0.2% -$11.8K 1.79% 7
2022
Q1
$6.21M Sell
8,886
-21
-0.2% -$14.7K 1.85% 9
2021
Q4
$5.63M Buy
8,907
+1,543
+21% +$974K 1.54% 10
2021
Q3
$4.46M Buy
7,364
+900
+14% +$545K 1.06% 16
2021
Q2
$3.61M Sell
6,464
-70
-1% -$39.1K 0.83% 37
2021
Q1
$3.09M Buy
6,534
+952
+17% +$450K 0.75% 43
2020
Q4
$2.7M Sell
5,582
-90
-2% -$43.5K 0.71% 45
2020
Q3
$3.18M Sell
5,672
-55
-1% -$30.8K 0.94% 27
2020
Q2
$3.57M Sell
5,727
-75
-1% -$46.8K 1.16% 22
2020
Q1
$2.83M Buy
5,802
+165
+3% +$80.6K 1.07% 29
2019
Q4
$2.12M Buy
5,637
+50
+0.9% +$18.8K 0.74% 40
2019
Q3
$1.55M Buy
5,587
+113
+2% +$31.4K 0.5% 52
2019
Q2
$1.71M Buy
5,474
+238
+5% +$74.5K 0.54% 52
2019
Q1
$2.15M Hold
5,236
0.61% 42
2018
Q4
$1.96M Buy
5,236
+755
+17% +$282K 0.74% 39
2018
Q3
$1.81M Buy
4,481
+38
+0.9% +$15.4K 0.62% 48
2018
Q2
$1.53M Buy
+4,443
New +$1.53M 0.59% 49